Could IL-17A be a novel therapeutic target in diabetic nephropathy?

Carolina Lavoz, Sandra Rayego-Mateos, Macarena Orejudo, Lucas Opazo-Ríos, Vanessa Marchant, Laura Marquez-Exposito, Antonio Tejera-Muñoz, Juan F. Navarro-González, Alejandra Droguett, Alberto Ortiz, Jesús Egido, Sergio Mezzano, Raúl R. Rodrigues-Diez, Marta Ruiz-Ortega

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Could IL-17A be a novel therapeutic target in diabetic nephropathy?'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science